Meco PG Tablet is a combination pharmaceutical formulation containing Methylcobalamin 750 mcg and Pregabalin 75 mg, designed for the management of neuropathic pain and related neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal function. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channel activity in the central nervous system, thereby reducing the release of excitatory neurotransmitters involved in pain signaling. This synergistic combination is indicated for conditions such as diabetic neuropathy, postherpetic neuralgia, peripheral neuropathies, and other chronic neuropathic pain syndromes. Meco PG Tablet aids in alleviating symptoms including burning, tingling, numbness, and shooting pain, improving patient quality of life. It is generally well-tolerated; however, potential side effects may include dizziness, somnolence, gastrointestinal disturbances, and allergic reactions. The dosage and duration of therapy should be individualized based on clinical response and tolerability, with careful monitoring in patients with renal impairment. Meco PG Tablet should be used under medical supervision, considering contraindications and drug interactions to ensure optimal therapeutic outcomes.